Point72 Asset Management
OLMA icon

Point72 Asset Management’s Olema Pharmaceuticals OLMA Stock Holding History

Point72 Asset Management’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$576K Buy
38,600
+24,500
+174% +$545K ﹤0.01% 3060
2025
Q4 		$353K Buy
+14,100
New +$251K ﹤0.01% 3406

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Point72 Asset Management's OLMA Position: Q1 2026 in Review

Point72 Asset Management reduced its Olema Pharmaceuticals (OLMA) stake by 77% in Q1 2026, selling an estimated $5.27M and leaving 71,107 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2729.

Point72 Asset Management first reported a position in OLMA in Q1 2021 and has held it in 9 quarters since. The position peaked at $44M in Q3 2024. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Point72 Asset Management held 71,107 shares of Olema Pharmaceuticals worth $1.06M as of Q1 2026.
  • Point72 Asset Management sold 236,783 Olema Pharmaceuticals shares in Q1 2026, an estimated $5.27M.
  • Olema Pharmaceuticals made up ﹤0.01% of Point72 Asset Management's portfolio in Q1 2026, its #2729 holding.
  • Point72 Asset Management first reported a position in Olema Pharmaceuticals in Q1 2021 and has held it in 9 quarters since.
  • Point72 Asset Management's Olema Pharmaceuticals position peaked at $44M in Q3 2024.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Point72 Asset Management's 13F filing for Q1 2026, filed 15 May 2026.